Background Nephrotic syndrome is primarily a pediatric disorder
HDL ratio between nephrotic syndrome in remission and control. There was also no significant difference in the incidence in relapse between first attack and nephrotic syndrome with more than two attacks. Acute lipid fraction levels were not risk factors in relapsing mephrotic syndrome. Remission triglyceride level was a risk factor 
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Request reprint to N ephrotic syndrome (NS) is the most common glomerular disorder in children. NS of NS. Hyperlipidemia is a constant appearance in minimal change nephrotic syndrome (MCNS) with Various lipid abnormalities have been described in MCNS during the active phase of the disease. These include increasing levels of serum (LDL) and very low density lipoprotein (VLDL). High [3] [4] [5] [6] Elevated plasma lipid levels are potential risk factors for atherosclerosis and progression of glomerular injury. Lipidemia may affect the kidneys directly or indirectly. Hyperlipidemia is also responsible for cardiovascular disease and progressive hyperlipidemia can lead to relapse of NS or treatmentof lipid abnormalities are important aspects in the management of NS in children. 4 
Methods
This prospective cohort study was carried out from three children were enrolled comprising 33 children other diseases that may influence the plasma lipids or subsequent attacks were included in this study.
Medical Ethics Committee approval were obtained.
NS was defined as a disease associated with all patients during the acute phase using the enzymatic colorimetric test. Three ml of venous blood were taken during the acute phase using a sterile syringe then divided into two labeled tubes (identity and date) and directly sent to the laboratory or stored in a refrigerator. The second sample of plasma lipids was collected during remission (maximum eight weeks after treatment).
collected as control. After collecting blood specimens achieve remission within eight weeks after treatment were diagnosed as having initial nonresponder NS and blood specimens for the determination of plasma lipids were collected. The patients were followed up six months after achievement of remission to determine whether they relapsed or were still in remission. Relapse was defined if there was massive proteinuria software. Comparison of plasma lipids levels during the acute phase and remission phase was analyzed using the student t test. The significant relationship between plasma lipids and relapses were analyzed using X test.
Results
as control were enrolled in the study. Three of the 33 patients with NS were excluded because they belonged to initial non-responder NS. The characteristics of the study subjects are depicted in Table 1 .
nutritional status were found between NS and control.
Comparison of plasma lipids levels between the acute phase and remission phase is shown in Table 2 . There were significant differences in plasma lipids levels between NS during the acute phase and remission. Comparison of plasma lipids between NS during remission and the control group is shown in Table 3 .
Significant differences were noted in total and control except for HDL. There were no significant differences in lipid fraction levels between the first attack and the second or subsequent attacks of NS during the acute phase. different between first attack and the second or subsequent attacks of NS.
There was no significant difference in the incidence of relapse between the first attack and second or There were no significant differences in plasma lipids levels during the acute phase between the two groups. During remission only cholesterol and triglyceride levels showed a significant difference between the two groups ( Table 4) . The relationship between lipid plasma level and the incidence of relapse showed that acute lipid fraction levels were not risk factor in relapsing NS. Only the triglyceride level during remission was a risk
Discussion
Hyperlipidemia is an important characteristic of NS. the disorder progresses.
The pathophysiology of nephrotic hyperlipidemia is complex and probably influenced by many factors. The prevailing view is that both hepatic syntheses of lipids and of apolipoproteins are increased and that the clearance of chylomicron and VLDL is reduced. Hyperlipidemia is also a risk factor for cardiovascular diseases and progressive glomerular damage leading to renal failure. Transient hypercholesterolemia in patients with steroidresponsive NS can be severe (e.g. serum cholesterol hypercholesterolemia and hypertriglyceridemia are common in patients who have treatment-resistant NS.
The sex ratio found in this study was similar to previous studies. There were highly significant NS during acute phase and remission. The total ratio were higher in the acute phase but the HDL level was lower. This may be ascribed to the urinary oncotic pressure leading to increased lipogenesis and decreased lipid catabolism. Significant differences needs more time to reduce the plasma lipids to a normal level or the initial conditions of the patients have a long duration of illness before admission may need a longer time to return back to normal. A cross sectional study by Sekarwana 11 showed that the mean level of each lipid profile in children with frequent study was conducted by cohort study concerning risk factor in relapses NS. Cholesterol and TG levels during remission were significantly different between persistent remission and relapse after six months remission. There was no significant difference in the incidence of relapse between the first attack and subsequent attacks of NS. The results of this study was different from a previous study done by Zilleruelo et al which showed that a significant number of children with MCNS during prolonged remission had elevated serum and severity of lipid changes correlated well with the duration of illness and frequency of relapses.
Acute lipid fraction levels were not risk factors in relapsing NS. Although the cholesterol and TG levels during remission were significantly different between persistent remission and relapse after six months but after statistical analysis cholesterol remission was not a risk factor in relapsing NS. Only triglyceride level during hyperlipidemia indicates that there is a progressive metabolic disorder which is related to the frequency of relapses or long term effect of corticosteroid therapy. 11 The primary finding in chronic renal failure and dialysis is hypertriglyceridemia. A study conducted by Rose and Appel showed that in patients with chronic increased of LDL cholesterol levels.
In this study only persistent hypertriglyceridemia risk of relapse. This persistent hypertriglyceridemia may be due to the fact that some patients had chronic NS and they probably had progressive renal injury marker for relapsing NS. This may be used to educate cause premature atherosclerosis. Therefore diet and antihyperlipidemic drugs could be considered in the management of the disease.
11 the lipid profile levels levels in infrequent and frequent relapses NS were and sVCAM-1 (marker of atherosclerosis) level were correlated significantly. The limitation of this study was that the diet of the patients at home and other factors that could trigger the relapses were not controlled. This determine the risk factors of a disease. Using the same treatment protocol for all patients was the strength of this study. remission phase is a risk factor for relapsing NS.
